Chromogranin 'A' in normal subjects, essential hypertensives and adrenalectomized patients

Clinical Endocrinology

Volumn 57, Issue 1, 2002, Pages 41-50

  Giampaolo, Bernini ^a   Angelica, Moretti ^a   Antonio, Salvetti ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CHROMOGRANIN A; GLUCAGON; INSULIN; NORADRENALIN;

ADRENALECTOMY; ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE; BLOOD SAMPLING; BODY POSTURE; CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE RELEASE; CIRCADIAN RHYTHM; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPOGLYCEMIA; IMMUNORADIOMETRIC ASSAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SUPINE POSITION;

ADRENAL GLANDS; ADRENALECTOMY; ADULT; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMOGRANIN A; CHROMOGRANINS; CIRCADIAN RHYTHM; EPINEPHRINE; FEMALE; GLUCAGON; HUMANS; HYPERTENSION; IMMUNORADIOMETRIC ASSAY; INSULIN; MALE; MIDDLE AGED; NOREPINEPHRINE; POSTURE;

EID: 0036069852     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2002.01557.x     Document Type: Article

References (47)

1. Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors
2. Chromogranin A: Post-translational modifications in secretory granules
3. Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours
4. A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours
5. Diagnostic specificity of serum chromogranin-A for pheochromocytoma in patients with renal dysfunction
6. Topology of chromogranins in secretory granules of endocrine cells
7. Characterisation of circulating chromogranin A in human cancer patients
8. Plasma chromogranin A as a marker of sympathochromaffin activity in humans
9. The tissue distribution of rat chromogranin A-derived peptides: Evidence for differential tissue processing from sequence specific antisera
10. Chromogranin A: Its role in endocrine function and as an endocrine and neuroendocrine tumour marker
11. A new human chromogranin A (CgA) immunoradiometric assay involving monoclonal antibodies raised against the unprocessed central domain (145-245)
12. Does chromogranin A respond to short-term mild physiologic challenge?
13. The biological characteristics of chromogranin A and its role as a circulating marker in neuroendocrine tumours
14. Chromogranin-A as a serum marker for neuroendocrine tumors: Comparison with neuron-specific enolase and correlation with immunohistochemical findings
15. Review: Chromogranin A
16. Chromogranin A in uremia: Progressive retention of immunoreactive fragments
17. Chromogranin A in familial pheochromocytoma: Diagnostic screening value, prediction of tumour mass, and post-resection kinetics indicating two-compartment distribution
18. Chromogranin A storage and secretion: Sensitivity and specificity for the diagnosis of pheochromocytoma
19. Chromogranin A in children with neuroblastoma: Serum concentration parallels disease stage and predicts survival
20. Library of sequence-specific radioimmunoassays for human chromogranin A
21. Plasma catecholamines in hypertension and pheochromocytomas determined using con-pair reversed-phase chromatography with amperometric detection
22. Intracellular and extracellular processing of chromogranin-A. Determination of cleavage sites
23. Distribution of chromogranin A-like peptides in the rat
24. Chromogranin A as serum marker for neuroendocrine neoplasia: Comparison with neuron-specific enolase and the α-subunit of glycoprotein hormones
25. Chromogranin A: Widespread immunoreactivity in polypeptide hormone producing tissues and in serum
26. Plasma chromogranin A. Initial studies in human hypertension
27. Radioimmunoassay of chromogranin A in plasma as a measure of exocytotic sympathoadrenal activity in normal subjects and patients with pheochromocytoma
28. Secretion of chromogranin A by peptide producing endocrine neoplasms
29. Chromogranin A, the major catecholamine storage vesicle soluble protein: Multiple size forms, subcellular storage, and regional distribution in chromaffin and nervous tissue elucidated by radioimmunoassay
30. Human chromogranin A. Purification and characterization from catecholamine storage vesicles of human pheochromocytoma
31. Malignant pheochromocytoma. Chromaffin granule transmitters and response to treatment
32. Catecholamine metabolic pathways and exercise training
33. The granin protein family: Markers for neuroendocrine cells and tools for the diagnosis of neuroendocrine tumors
34. Chromogranin A and chromogranin B are sensitive circulating markers for pheochromocytoma
35. Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours
36. Sympatho-adrenal secretion in humans: Factors governing catecholamine and storage vesicle peptide co-release
37. Chromogranin A. Storage and release in hypertension
38. Neuroendocrine sources of chromogranin-A in normal man: Clues from selective stimulation of endocrine glands
39. Is physiologic sympathoadrenal catecholamine release exocytotic in humans?
40. Ultradian variations of chromogranin A in humans
41. Chromogranin A in human hypertension. Influence of heredity
42. Comparison of chromogranin A and pancreastatin levels in plasma of patients with pancreatic islet cell tumor
43. Heterogeneity of chromogranin A-derived peptides in bovine gut, pancreas and adrenal medulla
44. Post-translational processing of chromogranin A: Differential distribution of phosphorylated variants of pancreastatin and fragments 248-313 and 297-313 in bovine pancreas and ileum
45. Undegraded chromogranin A is present in serum and enters the endocytotic lysosomal pathway in kidney
46. The chromogranins A and B: The first 25 years and future perspectives
47. Chromogranin A (210-301) is the major form of pancreastatin-like material in human gut extracts and endocrine tumors